Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PREDMETH Trial: Effectiveness of Methotrexate Versus Prednisone as First-line Therapy for Pulmonary Sarcoidosis - A Randomized Controlled Trial

NCT04314193 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT04314193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04314193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PREDMETH Trial: Effectiveness of Methotrexate Versus Prednisone as First-line Therapy for Pulmonary Sarcoidosis - A Randomized Controlled Trial
Lead sponsor
Erasmus Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
June 1, 2020
Completion date
July 31, 2026
Enrollment
138 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoidosis, pulmonary